Judy Koutlas, RN, MS, OCN
Vidant Medical CenterAuthored Items
Allyson H. Daugherty, PT, CLT, CFM, Judy Koutlas, RN, MS, OCN, Debra C. Mascarenhas, RN, BSN, BSBA, CBCN
September 23, 2016 | October 2016 Vol 7, No 9
Approximately 42% of breast cancer survivors develop clinically detectable lymphedema within 5 years of treatment. Early intervention and education is crucial to decrease long-term morbidity and improve patient outcomes.
Last modified: June 6, 2018